Navigation Links
RainTree Oncology Services Announces Service Agreement With Diplomat Specialty Pharmacy
Date:12/8/2011

SAN DIEGO, Dec. 8, 2011 /PRNewswire/ -- RainTree Oncology Services (RainTree Oncology), a privately-held provider of oral oncologic drug acquisition and management services, today announced it has signed a service agreement with Diplomat Specialty Pharmacy (Diplomat), the nation's largest privately-owned specialty pharmacy providing medication management and clinical services. The agreement will enable the Company to provide community oncology practices with better access to crucial oral oncology drugs, clinical programs and adherence-enhancing medication management programs.

"Diplomat is not only one of the nation's largest dispensers of many oral oncolytics, such as Revlimid and Zytiga, but also brings impressive oncology-specific programs and data collection capabilities," said Mike Martin, president and chief executive officer of RainTree Oncology. "Their resources align with our physician centric, patient focused initiative to provide important data to community oncology practices. This will enable our customers to better support cancer care through analysis of cancer patient compliance, adherence and outcomes."

"We are honored to be chosen by Raintree to be their specialty pharmacy partner," said Phil Hagerman, Diplomat's president and chief executive officer.  "Working in close partnership with Raintree will facilitate enhanced services to Raintree physicians and improved outcomes for their patients. This model will secure access to complex oral oncolytics as well as implement drug-specific algorithms that will help mimic clinical trial efficacy."            

In the United States, community oncologists provide care for the majority of cancer patients. Increasingly, changes in healthcare economics are impacting how these practices operate, putting pressure on their ability to deliver essential services to their patients. Oral drug acquisition and management can be particularly problematic as the drugs are expensive and often are not fully reimbursed.

RainTree Oncology is building a network of community oncologists through which members will obtain pharmaceuticals at contracted prices - a savings that could be passed onto the patient or used to enhance patient services. In addition, RainTree Oncology will facilitate the implementation of in-practice pharmacies for practices that do not have one, providing an added convenience for patients and a key source of information for physicians.

Using technology tools provided by RainTree, practice pharmacists will be able to track both the prescribing and fulfillment of oral oncology medications in practices, as well as patient utilization of these drugs. Practice physicians and administrators can then use the information to elevate practice care and improve operations.

About RainTree Oncology Services
RainTree Oncology Services provides leading-edge oral drug acquisition and management services that make a difference in the lives of cancer patients by helping community oncology practices expand services and improve patient care, enhancing the economic model of community oncology practices and pioneering an integrated information network between physicians, payors and manufacturers to advance state of the art in oral oncology. RainTree Oncology is physician centric, patient focused and community minded. For more information about RainTree Oncology Services: www.raintreeoncology.com.

About Diplomat Specialty Pharmacy
Michigan-based Diplomat Specialty Pharmacy, founded in 1975, serves patients nationwide as the country's largest privately held Specialty Pharmacy and focuses on complete medication management programs for patients with serious and chronic conditions. Diplomat creates unique programs with specialty distribution at retail focusing on improving adherence and the patient experience, as well as creating exclusive distribution models for its pharmaceutical partners. Learn more about Keeping Patients Healthier…Longer® at www.diplomatpharmacy.com


'/>"/>
SOURCE RainTree Oncology Services
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. The US Oncology Network to Present Webinar on Value-Based Reimbursement
2. Successful Market Education Strategies and Tactics for New Pharmaceutical Product Launches in the Oncology Therapeutic Area
3. Campbell Alliance Announces Windhover Top 10 Oncology Projects for 2011
4. OncologyRx Care Advantage™ Chosen to Fill Prescriptions for Jakafi™ (ruxolitinib)
5. Delcath Announces Agreement With European Institute of Oncology for Initial Launch of Hepatic Chemosat Delivery System in the European Union
6. Updated Survival Data from Study Comparing TTF™ (Tumor Treating Fields) Therapy to Best Standard Chemotherapy for Recurrent Glioblastoma Reported at the 16th Annual Scientific Meeting of the Society for NeuroOncology
7. Analytical Tool - Antibodies and Peptides in Oncology
8. Northwest Bio to Present at Society of Neuro-Oncology Annual Meeting
9. Medical Oncology Association of Southern California, Cardinal Health Specialty Solutions Collaborate With Payors to Improve Quality, Costs, Accessibility of Cancer Care
10. Caliper Launches New Platform for Drug Safety Prediction and Oncology Research
11. Champions Oncology, Inc. Appoints Executive Vice President and Chief Financial Officer to Management Team and Corporate Office Relocation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... , Jan. 19, 2017   Science Exchange ... excited to announce that the first five replication ...  (RP:CB) have been published in eLife today. Despite ... represents the first practical evaluation of reproducibility rates ... reproducible studies. Unlike other assessments of reproducibility, the ...
(Date:1/19/2017)... Marks E-QURE , s 3 ... similar agreements in Israel and Argentina ... 5 billion global market ... medical devices for the treatment of advanced wound care, announced today it signed ... Colombia for the Company,s patented Bio-electrical Signal Therapy device ("BST ...
(Date:1/19/2017)... The drug delivery technology market is projected ... 1,179.20 billion in 2016, at a CAGR of 7.2% ... diseases, increasing demand for biologics, technological advancements, and new ... this market. Whereas, self-administration & home care and rising ... opportunities for players operating in this market. On the ...
Breaking Medicine Technology:
(Date:1/20/2017)... ... ... “The Land of More and More”: a brilliant story for children ... the simple and achievable answer. “The Land of More and More” is the creation ... in Angola, Indiana where he works with the children’s ministry department. , Michael ...
(Date:1/19/2017)... ... ... Today, the Centers for Medicare & Medicaid Services (CMS) announced over 359,000 clinicians ... 2017. Clinicians who participate in APMs are paid for the quality of care they ... to build a system that delivers better care and one in which clinicians work ...
(Date:1/19/2017)... ... ... Next week after January 20th, the fear for many is that the humane ... of over 30 million. Many interviews with Dr. Carol Francis at the Los Angeles ... suppose to prioritize. Interviews provided below. , Among those present was Senator ...
(Date:1/19/2017)... ... January 19, 2017 , ... With the cold weather here, many people will have to clear ... when clearing large amounts of snow, but they can be dangerous when used incorrectly. That’s ... Safety Commission for the proper use of snow blowers:, , When ...
(Date:1/19/2017)... ... January 19, 2017 , ... LabRoots ... scientists from around the world, announces the launch of its newly redesigned website. ... portal to research breakthroughs and trending news, vital information on upcoming virtual events ...
Breaking Medicine News(10 mins):